Cost-Effectiveness of Point-of-Care Hepatitis C Virus RNA Testing in the US

Key Points

• This analysis evaluates the cost-effectiveness of hepatitis C virus testing strategies using point-of-care (POC) approaches.
• Economic analysis comparing different HCV testing strategies
• Focus on point-of-care HCV RNA-first approach
• Targeted towards high-risk populations
• POC HCV RNA-first approach identified as cost-effective
• Clinically optimal for high-risk populations
• Supports efforts for hepatitis C virus elimination in the US